Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02743481 · ClinicalTrials.gov registry record
Early Life Exposures in Agriculture
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 60,000
- Enrollment target
NCT02743481: Completed study, sponsored by National Cancer Institute (NCI).
NCT02743481 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 60,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02743481 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 60,000 participants
- Enrollment target
Study Summary
Background: The Agricultural Health Study (AHS) studied farmers and their spouses in North Carolina and Iowa. It also included people who worked with pesticides in Iowa. They answered a questionnaire and gave data about their children born since 1975. Researchers want to link this data to public data like birth and death certificates. They want to study how early life exposures to farms are linked to cancer and other bad health outcomes. Objective: To study data to find links between early life farm exposure and negative health outcomes. Eligibility: There will be no human subjects. Design: Researchers will get public data in the two study states. This will come from things like: Birth certificates Driver s licenses Voter registration Death certificates Based on these plus the AHS data, they will create a study group. It will be called Early Life Exposure in Agriculture (ELEA). Researchers will link ELEA data to cancer data. This will identify prevalence of cancer. They will study parents answers on the AHS. The topics include farm practices and pesticide use. They will determine ELEA exposure to pesticides. Researchers will analyze the cancer and pesticide results and look for links.
Primary Outcome
Cancer incidence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,000 participants |
| Start Date | 2016-04-14 |
| Est. Completion | 2020-04-15 |
What the finished NCT02743481 record still lists
NCT02743481 is an observational study that tracks outcomes without assigning an intervention. Its 60,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02743481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02743481 about?
NCT02743481 is a clinical study titled "Early Life Exposures in Agriculture". Background: The Agricultural Health Study (AHS) studied farmers and their spouses in North Carolina and Iowa. It also included people who worked with pesticides in Iowa. They answered a questionnaire and gave data about their children born since 1975. Researchers want to link this data to public da...
What is the current status of trial NCT02743481?
This trial is currently completed. The enrollment target is 60,000 participants. The study started on 2016-04-14. Estimated completion is 2020-04-15.
Who is sponsoring clinical trial NCT02743481?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT02850588 · 60,000 participants
SVS VQI TransCarotid Revascularization Surveillance Project
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI